BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Trichostatin A
,
rs2300478
,
BRAF
,
glucose metabolic process
,
Leukemia
,
Kidney
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
cabozantinib
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
HBB
CRIP1
SERPINA3
LCN2
COL11A1
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
MODULE_3
PUJANA_BRCA1_PCC_NETWORK
nucleoplasm
heterocyclic compound binding
organic cyclic compound binding
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
L1000 CMAP - Motor neuron MNEU.E cells treated with small molecule perturbagens
L1000 CMAP - Embryonic stem HUES3 cells treated with small molecule perturbagens
Multiple cancer cell lines treated with 32 kinase inhibitors
Prostate cancer LuCaP-93 xenografts from SCID mice treated with cabozantinib
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Irreversible Cabozantinib-induced left ventricular systolic dysfunction, a potentially novel observa…
Real-world Practice Patterns and Safety of Concurrent Radiotherapy and Cabozantinib in Metastatic Re…
Bilateral optic disc edema as a possible complication of cabozantinib use-a case report.
The influence of several nutritional supplements on the rational use of cabozantinib.
Cabozantinib exposure-response analysis for the phase 3 CheckMate 9ER trial of nivolumab plus caboza…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Cabozantinib With Topotecan-Cyclophosphamide
Cabozantinib in Advanced Solid Malignancies
Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors
Cabozantinib and Pembrolizumab for Advanced Metastatic Melanoma
Cabozantinib and Nivolumab for Carcinoid Tumors
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ